Medtronic (XSWX:MDT) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MDT Medtronic PLC XSWX:MDT
76 GF Score
Price CHF69.82
GF Value CHF80.28
! 3 Warning Signs
View Full Analysis

What is Medtronic Short-term investments?

Short-term investments only applies to insurance companies.

XSWX:MDT
76GF Score
Medtronic PLC XSWX:MDT
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medtronic (XSWX:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of CHF69.82 is trading 13% below its estimated GF Value™ of CHF80.28.

Key valuation signals for XSWX:MDT:

  • Short-term investments:
  • GF Value™: CHF80.28 vs. price of CHF69.82 (13% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
76GF Score

Get the complete analysis for XSWX:MDT

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF69.82
Price
CHF80.28
GF Value